Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/45327
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Le Goff, C. | en_US |
dc.contributor.author | Cavalier, E. | en_US |
dc.contributor.author | Souberbielle, J. C. | en_US |
dc.contributor.author | González-Antuña, A. | en_US |
dc.contributor.author | Delvin, E. | en_US |
dc.date.accessioned | 2018-11-22T08:58:37Z | - |
dc.date.available | 2018-11-22T08:58:37Z | - |
dc.date.issued | 2015 | en_US |
dc.identifier.issn | 2352-5517 | en_US |
dc.identifier.uri | http://hdl.handle.net/10553/45327 | - |
dc.description.abstract | The constantly increasing requests for the measurement of serum 25-hydroxyvitamin D over the last years has led reagent manufacturers to market different automated and semi-automated methods, that being unfortunately not fully harmonized, yield different results. Liquid chromatography coupled to tandem mass spectrometry (LC/MS2) has more recently been introduced. This approach allows the distinction between the two forms of 25-hydroxyvitamin D and to measure other metabolites. This approach also requires harmonization to curtail the differences between the different analytical methods. To meet this requirement, the American National Institutes of Health (NIH), the Centre for Disease Control and Prevention (CDC) in Atlanta, the National Institute of Standards and Technology (NIST) and the vitamin D Reference laboratory of Ghent University have pooled their expertise to develop a standardization program. This article reviews the main elements and the difficulties of the automated and semi-automated methods for 25-hydroxyvitamin D, from sample preparation to the analytical phase, as well as those related to mass spectrometry. It also emphasizes the need for standardization to better define the clinical decision thresholds of vitamin D nutritional status. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Practical Laboratory Medicine | en_US |
dc.source | Practical Laboratory Medicine [2352-5517], v. 2, p. 1-14 | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 2403 Bioquímica | en_US |
dc.subject.other | Vitamin D | en_US |
dc.subject.other | 25-Hydroxycholecalciferol | en_US |
dc.subject.other | 25-Hydroxyergocalciferol | en_US |
dc.subject.other | HPLC | en_US |
dc.subject.other | Mass spectrometry | en_US |
dc.subject.other | Immunoassays | en_US |
dc.title | Measurement of circulating 25-hydroxyvitamin D: A historical review | en_US |
dc.type | info:eu-repo/semantics/review | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1016/j.plabm.2015.04.001 | en_US |
dc.identifier.scopus | 84938055372 | - |
dc.contributor.authorscopusid | 8618411500 | - |
dc.contributor.authorscopusid | 12796112400 | - |
dc.contributor.authorscopusid | 7005743181 | - |
dc.contributor.authorscopusid | 36058862700 | - |
dc.contributor.authorscopusid | 35464025700 | - |
dc.description.lastpage | 14 | en_US |
dc.description.firstpage | 1 | en_US |
dc.relation.volume | 2 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Reseña | en_US |
dc.description.numberofpages | 15 | en_US |
dc.utils.revision | Sí | en_US |
dc.date.coverdate | Agosto 2015 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.fullName | González Antuña, Ana | - |
Appears in Collections: | Reseña |
SCOPUSTM
Citations
50
checked on Nov 17, 2024
Page view(s)
39
checked on Sep 9, 2023
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.